A detailed history of Ancora Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 366 shares of BAX stock, worth $12,191. This represents 0.0% of its overall portfolio holdings.

Number of Shares
366
Previous 366 -0.0%
Holding current value
$12,191
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $7,516 - $10,514
200 Added 120.48%
366 $14,000
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $1,093 - $1,269
-22 Reduced 11.7%
166 $8,000
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $47,396 - $58,784
-880 Reduced 82.4%
188 $10,000
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $1,404 - $1,760
22 Added 2.1%
1,068 $69,000
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $23,439 - $27,282
-305 Reduced 22.58%
1,046 $81,000
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $23,439 - $27,282
305 Added 29.16%
1,351 $114,000
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $22,499 - $25,501
-305 Reduced 22.58%
1,046 $84,000
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $2,062 - $2,322
-27 Reduced 1.96%
1,351 $114,000
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $2,035 - $2,223
27 Added 2.0%
1,378 $111,000
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $78,660 - $94,140
-1,000 Reduced 42.54%
1,351 $116,000
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $180,321 - $207,945
2,351 New
2,351 $197,000
Q4 2018

Feb 15, 2019

SELL
$61.45 - $77.8 $111,040 - $140,584
-1,807 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$70.71 - $77.75 $73,750 - $81,093
-1,043 Reduced 36.6%
1,807 $139,000
Q2 2018

Aug 10, 2018

BUY
$63.43 - $75.41 $180,775 - $214,918
2,850 New
2,850 $210,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.